Green Cures Botanical Stock Gross Profit
GRCU Stock | USD 0.0002 0.0001 100.00% |
Green Cures Botanical fundamentals help investors to digest information that contributes to Green Cures' financial success or failures. It also enables traders to predict the movement of Green Pink Sheet. The fundamental analysis module provides a way to measure Green Cures' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Green Cures pink sheet.
Green |
Green Cures Botanical Company Gross Profit Analysis
Green Cures' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Green Cures Gross Profit | 989.6 K |
Most of Green Cures' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Green Cures Botanical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition |
According to the company disclosure, Green Cures Botanical reported 989.6 K of gross profit. This is 99.96% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
All Next | Launch Module |
Green Fundamentals
Return On Equity | 0.55 | |||
Return On Asset | 0.023 | |||
Profit Margin | 4.96 % | |||
Operating Margin | 0.62 % | |||
Current Valuation | 4.85 M | |||
Price To Sales | 2.80 X | |||
Revenue | 13.17 K | |||
Gross Profit | 989.6 K | |||
EBITDA | 861.7 K | |||
Net Income | (1.09 M) | |||
Cash And Equivalents | 80 K | |||
Cash Per Share | 0.04 X | |||
Total Debt | 3.1 M | |||
Debt To Equity | 0.09 % | |||
Current Ratio | 4.85 X | |||
Book Value Per Share | (2.23) X | |||
Cash Flow From Operations | (73.09 K) | |||
Earnings Per Share | 3.15 X | |||
Number Of Employees | 20 | |||
Beta | 1.09 | |||
Market Capitalization | 2.54 M | |||
Total Asset | 406 | |||
Retained Earnings | (1.58 M) | |||
Working Capital | (539 K) | |||
Current Liabilities | 539 K | |||
Z Score | -22.03 | |||
Net Asset | 406 |
About Green Cures Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Green Cures Botanical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Green Cures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Green Cures Botanical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Green Pink Sheet Analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.